Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FPyQCP PET Imaging in Selected Oncology Indications
NCT07432633Phase 2Recruiting
- Sponsor
- Blue Earth Diagnostics
- Start
- Feb 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 18F-FPyQCP in colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), Invasive Lobular Carcinoma (ILC), epithelial ovarian cancer (EOC), sponsored by Blue Earth Diagnostics. Started Feb 2026; status: recruiting.
02
Drugs
18F-FPyQCP
03
Conditions
colorectal cancer (CRC)gastric cancer (GC)pancreatic ductal adenocarcinoma (PDAC)Invasive Lobular Carcinoma (ILC)epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on NCT07432633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07432633.